Infliximab Dosing Patterns Among Individuals with Crohnʼs Disease: Results from a Mid-Atlantic Healthplan

Jennifer Lofland, Julie Vanderpoel, Charles Ruetsch, Winston Wong

Open source

DOI
10.14309/00000434-201210001-01491
Published
2012-10
Container
American Journal of Gastroenterology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14309/00000434-201210001-01491,
  title = {Infliximab Dosing Patterns Among Individuals with Crohnʼs Disease: Results from a Mid-Atlantic Healthplan},
  author = {Jennifer Lofland and Julie Vanderpoel and Charles Ruetsch and Winston Wong},
  year = {2012},
  journal = {American Journal of Gastroenterology},
  doi = {10.14309/00000434-201210001-01491},
  url = {https://doi.org/10.14309/00000434-201210001-01491}
}

RIS

TY  - JOUR
TI  - Infliximab Dosing Patterns Among Individuals with Crohnʼs Disease: Results from a Mid-Atlantic Healthplan
AU  - Jennifer Lofland
AU  - Julie Vanderpoel
AU  - Charles Ruetsch
AU  - Winston Wong
PY  - 2012
JO  - American Journal of Gastroenterology
DO  - 10.14309/00000434-201210001-01491
UR  - https://doi.org/10.14309/00000434-201210001-01491
ER  - 

APA

Lofland, J., Vanderpoel, J., Ruetsch, C., & Wong, W. (2012). Infliximab Dosing Patterns Among Individuals with Crohnʼs Disease: Results from a Mid-Atlantic Healthplan. American Journal of Gastroenterology. https://doi.org/10.14309/00000434-201210001-01491

Source records